Last reviewed · How we verify

NCT03388827

The Use of Laminaria Versus Laminaria Plus Misoprostol Before Operative Hysteroscopy in Nulliparous Women . A Double Blinded Randomized Trial.

Status unknown Phase 2 Last updated 6 December 2018
What this trial tests

Phase 2 trial testing Laminaria tent in Cervical Spasm in 100 participants. Status unknown.

Timeline
20 December 2017
Primary endpoint
1 December 2018
1 January 2019

Quick facts

Lead sponsorZagazig University
PhasePhase 2
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment100
Start date20 December 2017
Primary completion1 December 2018
Estimated completion1 January 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 18 to 45, female only, with Cervical Spasm. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Laminaria and Misoprostol before Operative Hysteroscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03388827.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing